Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone [Phase 3]
Phase 3 trial evaluating cognitive remediation in schizophrenia or schizoaffective disorder patients stabilized on lurasidone has completed …
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation [Phase 2]
Phase 2 trial evaluating whether omega-3 fatty acid supplementation lowers coronary artery disease risk in people with schizophrenia or schi…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry [Phase 2]
A Phase 2 trial sponsored by Janssen evaluated the clinical utility of measuring antipsychotic medication levels in plasma using LC-MS/MS. T…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Treatment of Schizoaffective Disorder Using Mifepristone [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating mifepristone for schizoaffective disorder was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Improving Care and Reducing Cost Study [NA]
A completed clinical trial update from Northwell Health. The study aims to improve care and reduce costs for schizophrenia, schizoaffective …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia [NA]
A ClinicalTrials.gov entry indicates the Family-Directed Cognitive Adaptation Program for individuals with schizophrenia has completed its s…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations [NA]
This clinical trial update notes the completion of a study evaluating computerized cognitive-behavioral therapy for auditory hallucinations …
-
FDA approval · 2017-02-23FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2017-02-23FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz (clozapine) filed by TruPharma LLC. The action constitutes FDA approval of the sup…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia [Phase 2]
Phase 2 clinical trial update on pregnenolone for cognitive and negative symptoms in schizophrenia and schizoaffective disorder. Results wer…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Conversion to Antipsychotic Monotherapy [NA]
The clinical trial NCT01368458 evaluating conversion to antipsychotic monotherapy in schizophrenia and schizoaffective disorder has been ter…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Open-label Ziprasidone Study for Psychosis Treatment in Adolescents [Phase 3]
This open-label Phase 3 trial evaluated ziprasidone for treating psychosis-related disorders in adolescents, including schizophreniform diso…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) [Phase 2]
Phase 2 trial update for transcranial magnetic stimulation for negative symptoms in schizophrenia and schizoaffective disorder. The study wa…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
This completed clinical trial evaluated nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder. The trial w…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1 [Phase 4]
Phase 4 trial of a nicotine patch for nicotine dependence in individuals with schizophrenia or schizoaffective disorder has been terminated.
-
CLINICAL_TRIALS research · 2016-12-08Clinical Trial Update: Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs [NA]
A clinical trial update examining how magnesium variations relate to cardiometabolic risk in patients taking antipsychotic medications.
-
FDA approval · 2016-11-29FDA Approved: CLOZAPINE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma's generic Clozapine under an original ANDA, authorizing its use as a treatment for schizophrenia (including tr…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Cognitive Remediation and Functional Skills Training in Schizophrenia [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating cognitive remediation and functional skills training for schizophrenia has completed. The study a…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis [NA]
This ClinicalTrials.gov entry reports a completed study on multi-disciplinary treatment for patients experiencing a first episode of psychos…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating RO4917838 on biomarker measures of cognitive dysfunction in participants with schizophrenia and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen [NA]
This update notes the completed status of a substudy within the OPTIMISE trial at Copenhagen, focusing on optimization of treatment and mana…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia [Phase 4]
Phase 4 trial evaluating valacyclovir augmentation for cognitive and functional remediation in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Extended Specialized Assertive Intervention for First Episode Psychosis [NA]
The University of Copenhagen reports completion of a trial evaluating an extended specialized assertive intervention for individuals with fi…
-
FDA approval · 2016-10-06FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) by Eli Lilly and Company to support the intramuscular for…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia [NA]
This document reports a completed pilot trial evaluating naltrexone for obesity in women with schizophrenia; results were posted in 2016.